299 related articles for article (PubMed ID: 34981748)
1. 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.
Mooij CF; Cheetham TD; Verburg FA; Eckstein A; Pearce SH; Léger J; van Trotsenburg ASP
Eur Thyroid J; 2022 Jan; 11(1):. PubMed ID: 34981748
[TBL] [Abstract][Full Text] [Related]
2. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
3. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
4. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
[TBL] [Abstract][Full Text] [Related]
5. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.
Parameswaran R; de Jong MC; Kit JLW; Sek K; Nam TQ; Thang TV; Khue NT; Aye TT; Tun PM; Cole T; Miller JA; Villa M; Khiewvan B; Sirinvaravong S; Sin YL; Muhammad R; Jap TS; Agrawal A; Rajput R; Fernando R; Sumanatilleke M; Suastika K; Shong YK; Lang B; Bartalena L; Yang SP;
Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592
[TBL] [Abstract][Full Text] [Related]
6. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
7. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
[TBL] [Abstract][Full Text] [Related]
8. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
9. Anti-thyroid drugs in pediatric Graves' disease.
John M; Sundrarajan R; Gomadam SS
Indian J Endocrinol Metab; 2015; 19(3):340-6. PubMed ID: 25932387
[TBL] [Abstract][Full Text] [Related]
10. Graves' Disease in Children: An Update.
Metwalley KA; Farghaly HS
Clin Med Insights Endocrinol Diabetes; 2023; 16():11795514221150615. PubMed ID: 37151843
[TBL] [Abstract][Full Text] [Related]
11. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Graves' disease: management in the post-propylthiouracil Era.
Rivkees SA
Int J Pediatr Endocrinol; 2014; 2014(1):10. PubMed ID: 25089127
[TBL] [Abstract][Full Text] [Related]
13. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
14. Definitive treatment of Graves' disease in children and adolescents.
Król A; Czarniecka A; Jarząb B
Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
[TBL] [Abstract][Full Text] [Related]
15. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
16. A 2011 survey of clinical practice patterns in the management of Graves' disease.
Burch HB; Burman KD; Cooper DS
J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
[No Abstract] [Full Text] [Related]
18. Pediatric Graves' disease: controversies in management.
Rivkees SA
Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves' Disease: A Systematic Review.
Lutterman SL; Zwaveling-Soonawala N; Verberne HJ; Verburg FA; van Trotsenburg ASP; Mooij CF
Eur Thyroid J; 2021 Jul; 10(5):353-363. PubMed ID: 34540705
[TBL] [Abstract][Full Text] [Related]
20. Comparison Between the Treatment Modalities for Graves' Disease at King Abdulaziz Medical City, Jeddah.
Zarif HA; Alam SS; Baashar A; Alsharif A; Alhilabi M
Cureus; 2020 Jan; 12(1):e6730. PubMed ID: 32015936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]